FERRARI, VERONICA
 Distribuzione geografica
Continente #
AS - Asia 8.773
EU - Europa 8.284
NA - Nord America 8.198
Continente sconosciuto - Info sul continente non disponibili 779
SA - Sud America 628
AF - Africa 205
OC - Oceania 89
Totale 26.956
Nazione #
US - Stati Uniti d'America 7.783
CN - Cina 2.545
IT - Italia 2.357
DE - Germania 2.356
SG - Singapore 2.257
GB - Regno Unito 1.211
BD - Bangladesh 1.015
HK - Hong Kong 730
VN - Vietnam 670
BR - Brasile 473
RU - Federazione Russa 440
IN - India 405
SE - Svezia 393
FR - Francia 342
JP - Giappone 296
CA - Canada 286
NL - Olanda 275
KR - Corea 255
IE - Irlanda 154
ID - Indonesia 148
FI - Finlandia 136
DK - Danimarca 133
TR - Turchia 103
CI - Costa d'Avorio 100
AU - Australia 84
BE - Belgio 84
TW - Taiwan 81
PL - Polonia 73
ES - Italia 65
MX - Messico 58
CH - Svizzera 48
AT - Austria 44
AR - Argentina 43
UA - Ucraina 39
ZA - Sudafrica 31
EC - Ecuador 30
IQ - Iraq 28
IL - Israele 27
PH - Filippine 27
PK - Pakistan 27
CL - Cile 24
CO - Colombia 24
IR - Iran 20
EG - Egitto 19
GR - Grecia 18
SA - Arabia Saudita 16
HU - Ungheria 15
SI - Slovenia 15
NP - Nepal 14
CR - Costa Rica 13
MY - Malesia 12
TH - Thailandia 12
UZ - Uzbekistan 12
KE - Kenya 11
MO - Macao, regione amministrativa speciale della Cina 11
CZ - Repubblica Ceca 10
MA - Marocco 10
RO - Romania 10
VE - Venezuela 10
AE - Emirati Arabi Uniti 9
GT - Guatemala 9
PT - Portogallo 9
TN - Tunisia 9
LT - Lituania 8
LU - Lussemburgo 8
PE - Perù 8
TT - Trinidad e Tobago 8
NO - Norvegia 6
PY - Paraguay 6
BB - Barbados 5
HN - Honduras 5
JM - Giamaica 5
JO - Giordania 5
KZ - Kazakistan 5
LB - Libano 5
NI - Nicaragua 5
NZ - Nuova Zelanda 5
PR - Porto Rico 5
SC - Seychelles 5
AD - Andorra 4
AL - Albania 4
AZ - Azerbaigian 4
BA - Bosnia-Erzegovina 4
BO - Bolivia 4
DZ - Algeria 4
ET - Etiopia 4
GE - Georgia 4
HR - Croazia 4
RS - Serbia 4
SV - El Salvador 4
AM - Armenia 3
BH - Bahrain 3
CY - Cipro 3
KG - Kirghizistan 3
LV - Lettonia 3
MM - Myanmar 3
MT - Malta 3
NG - Nigeria 3
PA - Panama 3
UY - Uruguay 3
Totale 26.132
Città #
Hanover 1.426
Singapore 1.330
Ashburn 1.082
Southend 807
Milan 714
Hong Kong 587
San Jose 522
Santa Clara 445
Frankfurt am Main 438
Beijing 381
Chandler 352
Council Bluffs 343
Dallas 311
New York 274
Hefei 256
Los Angeles 242
Ho Chi Minh City 198
Fairfield 187
Hanoi 160
Boardman 154
Dublin 151
Wilmington 144
Seoul 139
Princeton 130
Jakarta 127
Bengaluru 126
Ann Arbor 123
Shanghai 123
Munich 122
Rome 112
Lauterbourg 111
Buffalo 107
Cambridge 107
Seattle 107
Guangzhou 102
Phoenix 101
Abidjan 100
Chicago 92
Tokyo 88
Moscow 86
Houston 85
Redwood City 85
Dearborn 79
Helsinki 79
Philadelphia 79
The Dalles 74
Woodbridge 73
Naples 62
Istanbul 60
Nanjing 58
Grafing 55
Medford 54
Toronto 54
Turin 54
Nuremberg 53
Cangzhou 51
Atlanta 49
Des Moines 49
Da Nang 47
São Paulo 47
Boston 45
Montreal 44
Shenyang 40
Basingstoke 39
Irvine 39
Tianjin 39
Zhengzhou 39
Amsterdam 38
Delhi 38
Jinan 37
Taichung 37
Brooklyn 36
Magenta 36
Mumbai 34
Wuhan 34
Columbus 33
Genoa 33
Fuzhou 31
San Francisco 30
Warsaw 30
Florence 29
Indianapolis 29
Bologna 28
Haiphong 27
Honolulu 27
Changsha 26
Chennai 26
Dong Ket 26
London 26
Nanchang 26
Palermo 26
Turku 26
Vienna 25
Berlin 24
Brussels 24
Charlotte 24
Quanzhou 24
Washington 24
Lappeenranta 23
Shenzhen 22
Totale 14.998
Nome #
Trehalose induces autophagy via lysosomal-mediated TFEB activation in models of motoneuron degeneration 1.249
The small heat shock protein B8 (HSPB8) efficiently removes aggregating species of dipeptides produced in C9ORF72-related neurodegenerative diseases 577
Autophagic and Proteasomal Mediated Removal of Mutant Androgen Receptor in Muscle Models of Spinal and Bulbar Muscular Atrophy 570
Transforming Growth Factor beta 1 signaling is altered in the spinal cord and muscle of amyotrophic lateral sclerosis mice and patients 551
Tdp-25 Routing to Autophagy and Proteasome Ameliorates its Aggregation in Amyotrophic Lateral Sclerosis Target Cells 539
Retinoic Acid Downregulates HSPB8 Gene Expression in Human Breast Cancer Cells MCF-7 493
VALOSIN CONTAINING PROTEIN IN AMYOTROPHIC LATERAL SCLEROSIS: NEW INSIGHT IN PATHOLOGICAL MECHANISMS 466
The Role of the Heat Shock Protein B8 (HSPB8) in Motoneuron Diseases 321
Molecules capable to induce neuroprotection via lysophagy activation 312
Analysis of the autophagic response in models of KIF5A-related neurodegeneration 312
Enhanced Clearance of Neurotoxic Misfolded Proteins by the Natural Compound Berberine and Its Derivatives 308
Bicalutamide and Trehalose Ameliorate Spinal and Bulbar Muscular Atrophy Pathology in Mice 294
The role of Extracellular Vesicles (EVs) in Amyotrophic Lateral Sclerosis (ALS) and frontotemporal lobar degeneration (FTLD) 285
The regulation of the small heat shock protein B8 in misfolding protein diseases causing motoneuronal and muscle cell death 283
HSPB8 frameshift mutant aggregates weaken chaperone-assisted selective autophagy in neuromyopathies 279
Chaperone Assisted Selective Autophagy (CASA) a potential target for therapeutics in motoneuron diseases 277
Molecular mechanisms in KIF5A-related neurodegeneration 272
BAG1 assists the degradation of neurotoxic proteins related to motor neuron diseases counteracting dynein-mediated autophagy alteration 270
Multiple Roles of Transforming Growth Factor Beta in Amyotrophic Lateral Sclerosis 267
Motor neuron degeneration in spinal and bulbar muscular atrophy: molecular approaches to counteract mutant androgen receptor neurotoxicity 261
A Crucial Role for the Protein Quality Control System in Motor Neuron Diseases 261
Generation of novel induced pluripotent stem cell models for the study of spinocerebellar ataxia type 17 251
Small heat shock protein B8: from cell functions to its involvement in diseases and potential therapeutic applications 251
Alternative Translation Initiation as a novel strategy to block toxicity of the mutant Androgen Receptor in SBMA 249
RAN translated C9ORF72 arginine rich poly-dipeptides alter gene transcription in ALS/FTD cell model 243
TDP-43 PROTEINOPATHIES: THE ROLE OF EXTRACELLULAR VESICLES 241
TDP25 aggregation in motor neuron and muscle cells is rescued by chaperone overexpression 239
Identification of new HSPB8 variants linked to familial Amiotrophic Lateral Sclerosis 239
Pathogenic variants of Valosin Containing Protein induce lysosomal damage and transcriptional activation of autophagy regulators in neuronal cells 237
The clearance of aggregated TDP-43 responsible for ALS/FTD diseases 231
STIP1 Homology And U-Box Containing Protein 1 (STUB1/CHIP) mutants as a key factor on TATA-box binding protein (TBP) behaviour in digenic spinocerebellar ataxia type 17 (SCA17-DI) 229
Valosin Containing Protein (VCP): A Multistep Regulator of Autophagy 228
Effect of Hspb8 deletion in the skeletal muscle of a mouse model for Amyotrophic Lateral Sclerosis 227
Extracellular vesicles and the secretion of TDP species in Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Lobar Degeneration (FTLD) 227
VCP mutants cause lysosomal alterations and autophagy induction in ALS-neuronal model 227
ALS-associeted VCP-mutants lead to lysosome damage 224
Bicalutamide and Trehalose as a therapeutic approach for SBMA 219
Insights on human small heat shock proteins and their alterations in diseases 217
Neurodegenerative Disease-Associated TDP-43 Fragments Are Extracellularly Secreted with CASA Complex Proteins 217
Chaperone mediated autophagy respond to dynein mediated transport inhibition in motor neuron diseases 216
STUB1 mutants effect on TBP behavior in digenic spinocerebellar ataxia type 17 212
How PQC inhibition modulates miRNA loading in large and small extracellular vesicles 211
Chaperone mediated autophagy responds to macroautophagy inhibition in motor neuron diseases 209
Extracellular vesicles cooperate with PQC system for the clearance of TDP-43 species associated with ALS and FTD 208
The BAG1 molecular chaperone regulators prevent ALS related neurotoxic misfolded proteins accumulation via proteasome and chaperone mediated autophagy 208
Altered molecular and cellular mechanisms in KIF5A-associated neurodegenerative or neurodevelopmental disorders 206
Amyotrophic lateral sclerosis related proteins are actively removed by HspB8 203
VCP modulation rescues C9ORF72 pathological features in ALS-neuronal models 202
VCP ALS-mutants induce lysosomal damage and autophagy activation 201
Mechanism of paroxetine-mediated autophagic induction in cell models of ALS/FTD 199
Novel pathogenic mechanism of ALS-associated VCP- mutants 198
C9ORF72 arginine rich poly-dipeptides induce transcriptional alterations in ALS/FTD cell model 198
Clearance of misfolded proteins in motoneuron disease: the case of Spinal and Bulbar Muscular Atrophy 196
Mutations in VCP induce lysosomal alterations and autophagy activation in ALS neuronal models 195
Chaperone-assisted selective autophagy in Health and Disease 193
The role of autophagy-lysosomal pathway in motor neuron diseases 193
BAG1 prevents misfolded proteins accumulation when autophagy flux is blocked in neurodegenerative disorders 190
Alternative translation initiatin as a novel strategy to block toxicity of the mutant androgen receptor in SBMA 189
Differentiation of isogenic iPSC reporter lines to motoneurons as tools for familial and sporadic amyotrophic lateral sclerosis 189
Investigating the molecular mechanisms involved in KIF5A-related neurodegeneration 188
The nucleotide exchange factor BAG1 prevents neurotoxic misfolded proteins accumulation via proteasome and chaperone mediated autophagy 188
Trehalose and bicalutamide as therapeutic agents of Kennedy disease 187
VCP mutants induce lysosomal damage and autophagy activation in amyotrophic lateral sclerosis (ALS) 186
Targeting androgen receptor stability and degradation: approaches for developing a therapy for spinal and bulbar muscular atrophy 185
TDP43 inclusions are re-routes to autophagy by the activity of the small chaperone HspB8 185
The small heat shock protein B8 at the interplay between the intracellular degradative pathways in motoneuron disease 185
Characterization of two new mutations in the small Heat Shock protein B8 HSPB8 and impact in Amyotrophic Lateral Sclerosis cell models 185
Identification of HSPB8 modulators counteracting misfolded protein accumulation in neurodegenerative diseases 184
The role of Valosin Containing Protein (VCP) in the degradation of neurotoxic protein aggregates in Amyotrophic Lateral Sclerosis 184
VCP: a novel regulator of SOD1-G93A clearance in a als model 184
Insights into KIF5A-related pathways to neurodegeneration 183
One gene, many phenotypes: investigating KIF5A-linked neurodegeneration mechanisms 182
Clearance and transport of misfolded protein responsible for motor neuron diseases (MNDs) 182
Shared behaviours of KIF5A frameshift mutants in neurodevelopment and neurodegeneration 181
Mutant Androgen Receptor Alternative Translation Initiation as novel strategy to block toxicity in SBMA. 177
Role of the autophagic pathway in a muscle model of Spinal and Bulbar Muscular Atrophy 176
Novel role of VCP in the clearance of mutant-SOD1 in als 176
The role of extracellular vesicles in the removal of aggregated TDP43 responsible for ALS/FTD diseases 174
Autophagic removal of aggregating dipeptides produced in C9ORF72 related neurodegenerative diseases 173
VCP autophagic modulation rescues C9ORF72 pathological features in ALS-neuronal models 166
Design, synthesis and characterization of aryl bis-guanyl hydrazones as RNA binders of C9orf72 G4C2 extended repeats 166
The Role of Small Heat Shock Proteins in Protein Misfolding Associated Motoneuron Diseases 166
Autophagy mediated HSPB8 removal of aggregating dipeptides produced in C9ORF72 related neurodegenerative diseases 166
Insights into the neurodegenerative mechanisms associated with KIF5A mutations 165
Motor neuron degeneration in Spinal and Bulbar Muscular Atrophy: molecular approaches to counteract mutant androgen receptor neurotoxicity 164
Lysosome quality control in health and neurodegenerative diseases 163
Molecular defects in KIF5A-linked neurodegenerative and neurodevelopmental diseases 162
Autophagy Dysfunction in ALS: from Transport to Protein Degradation 162
Innovative high throughput screening identifies HSPB8 modulators counteracting misfolded protein accumulation in neurodegenerative diseases 162
Valosin Containing Protein cooperates in the removal of toxic mutated-SOD-1 aggregates in Neurodegenerative diseases 161
Valosin Containing Protein role in the clearance of toxic mutated-SOD1 aggregates in fALS 161
Large and small extracellular vesicles may contribute to the propagation of ALS and FTD carrying toxic TDP species and potentially harmful miRNAs 158
The chaperone HSPB8 removes insoluble forms of the C9ORF72 RAN translated dipeptides responsible for ALS/FTD 158
Transcriptional alterations induced by polyDPRs overexpression in neuronal cell model 158
Proteotoxic responses in amyotrophic lateral sclerosis 157
The role of extracellular vesicles in the removal of aggregated TDP-43 responsible for ALS/FTD diseases 157
Extracellular vesicles and their role in TDP-43 proteinopathies 155
Analysis of the pathogenetic mechanisms involved in KIF5A-related neurodegenerative disorders 154
The role of extracellular vesicles in TDP-43 proteinopathies 153
Unveiling novel players in HSPB8 pathology caused by frameshift mutations 149
Totale 23.667
Categoria #
all - tutte 74.553
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 74.553


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.691 0 135 140 246 262 294 277 236 281 293 236 291
2022/20231.800 138 207 150 129 147 275 100 150 220 37 146 101
2023/20242.576 95 165 267 400 478 92 136 164 107 181 265 226
2024/20254.348 154 296 161 477 429 215 192 429 206 472 422 895
2025/202610.930 934 737 854 770 1.016 571 1.287 450 942 756 1.443 1.170
2026/20271.051 884 167 0 0 0 0 0 0 0 0 0 0
Totale 26.956